HistoSonics, Inc. is extremely proud to announce the publication of our pivotal #HOPE4LIVER Trials data today. The prospective, international, multi-center, single arm #HOPE4LIVER Trials were designed to evaluate the safety and efficacy of histotripsy for the non-invasive destruction of primary (hepatocellular carcinoma) and metastatic liver tumors. Safety and efficacy were measured against performance goals established using real-world evidence from ablative therapies. The trials met the co-primary endpoints for technical success and safety, and this outcome is key as the investigators treated both primary and metastatic disease and represented a diverse group of liver experts with no prior experience performing histotripsy, signaling a quick learning curve. As a result of these early data, HistoSonics initiated planned commercialization of the Edison System in the first half of 2024, rapidly establishing histotripsy programs in leading academic and private institutions across the US and globally. To date, the accelerated clinical adoption of histotripsy has led to hundreds of histotripsy procedures completed by liver surgeons, interventional radiologists, and radiation oncologists with a high rate of success. These data are being prepared for publication later this year. Furthermore, longer-term 12-month efficacy data from #HOPE4LIVER is in analysis and in preparation for publication. We recognize the courage of the many patients and families who participated in these groundbreaking trials. Also, we are thankful to partner with visionary clinicians and hospital leaders who continue to champion histotripsy as a new category of care for their diverse patient populations. #Histotripsy #MinimallyInvasiveIsntMinimalEnough #HistoSonics
Marti Anderson
3mo
Can someone at HistoSonics, Inc. contact me. I understand it’s not covered by many major insurance companies and would like to know if your healthcare partners accept private pay and any idea on price range. I can be reached at 602-318-1695 thanks!
we are waiting for good results for patient's hope
Viravone C.
4mo
Love this
Billy O.
4mo
That's great!
Congratulations! Impressive achievement.
Michelle Svatos
4mo
Inspiring!
Joan Vidal-Jové
4mo
Excellent achievement!!!
Exciting times!
Happily Retired
4moCongratulations to all of you for a job well done! Any news on when this drug will be available in Canada? Thank you, Ricki.